AR103244A1 - Recipiente precargado con toxina botulínica - Google Patents
Recipiente precargado con toxina botulínicaInfo
- Publication number
- AR103244A1 AR103244A1 ARP150104254A ARP150104254A AR103244A1 AR 103244 A1 AR103244 A1 AR 103244A1 AR P150104254 A ARP150104254 A AR P150104254A AR P150104254 A ARP150104254 A AR P150104254A AR 103244 A1 AR103244 A1 AR 103244A1
- Authority
- AR
- Argentina
- Prior art keywords
- plastic container
- botulin toxin
- charged container
- filled plastic
- container
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31513—Piston constructions to improve sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0222—Materials for reducing friction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
Abstract
Un recipiente de plástico precargado, tal como una jeringa de plástico, que comprende una formulación de toxina botulínica acuosa. La formulación de toxina botulínica acuosa en el recipiente de plástico precargado es estable por un periodo más largo de tiempo. Un kit que comprende el recipiente de plástico precargado, y al uso de un recipiente de plástico precargado para fines terapéuticos y cosméticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15000310 | 2015-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR103244A1 true AR103244A1 (es) | 2017-04-26 |
Family
ID=52449922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150104254A AR103244A1 (es) | 2015-02-03 | 2015-12-22 | Recipiente precargado con toxina botulínica |
Country Status (15)
Country | Link |
---|---|
US (3) | US10406290B2 (es) |
EP (1) | EP3253364A1 (es) |
JP (2) | JP6813492B2 (es) |
KR (1) | KR102627068B1 (es) |
CN (1) | CN107206175B (es) |
AR (1) | AR103244A1 (es) |
AU (1) | AU2015381351B2 (es) |
BR (1) | BR112017016759B1 (es) |
CA (1) | CA2974450C (es) |
IL (1) | IL253429B (es) |
MX (1) | MX2017009380A (es) |
RU (1) | RU2722290C2 (es) |
SG (1) | SG11201706247VA (es) |
TW (1) | TWI728964B (es) |
WO (1) | WO2016124213A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499981B (zh) * | 2005-03-03 | 2016-08-03 | 雷文斯治疗公司 | 用于局部施用和经皮肤递送肉毒杆菌毒素的组合物和方法 |
US8168206B1 (en) * | 2005-10-06 | 2012-05-01 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
US10792344B2 (en) * | 2006-06-29 | 2020-10-06 | Merz Pharma Gmbh & Co. Kgaa | High frequency application of botulinum toxin therapy |
SG11201705019PA (en) * | 2014-12-23 | 2017-07-28 | Merz Pharma Gmbh & Co Kgaa | Botulinum toxin prefilled container |
SG11201706247VA (en) | 2015-02-03 | 2017-08-30 | Merz Pharma Gmbh & Co Kgaa | Botulinum toxin prefilled container |
TWI737742B (zh) * | 2016-06-22 | 2021-09-01 | 德商梅茲製藥有限兩合公司 | 肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用 |
WO2020074419A1 (en) * | 2018-10-08 | 2020-04-16 | Merz Pharma Gmbh & Co. Kgaa | Neurotoxin prefilled vial |
RS61232B1 (sr) * | 2018-11-30 | 2021-01-29 | Klaus Stegemann | Špric za primenu koji sadrži sterilni rastvor sa medicinski aktivnom supstancom i postupak za pripremu istog |
CN113573727A (zh) | 2019-02-21 | 2021-10-29 | 梅尔兹制药公司 | 肉毒神经毒素用于治疗震颤的新用途 |
US11054185B1 (en) * | 2020-02-24 | 2021-07-06 | Lyophilization Technology, Inc. | Apparatus for lyophilization of products contained in product delivery units |
EP3875131A1 (en) | 2020-03-06 | 2021-09-08 | Schott AG | Pharmaceutical packaging receptacle with a lubricant layer for removal of a charge |
KR102404217B1 (ko) * | 2020-04-08 | 2022-06-02 | (주)메디톡스 | 토출 속도 조절이 용이하고 안정한 보툴리눔 독소 사전충전된 주사기 제형 |
CN115397399A (zh) * | 2020-04-08 | 2022-11-25 | 玫帝托克斯股份有限公司 | 一种易于控制排出速度且稳定的肉毒杆菌毒素预填充式注射器剂型 |
WO2021042090A2 (en) * | 2020-11-27 | 2021-03-04 | Schott Ag | System for long time storage of pharmaceutical compositions at low temperatures |
US20230204611A1 (en) * | 2021-12-28 | 2023-06-29 | Dionex Corporation | Identification of sample cells in a chromatography autosampler |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607400A (en) | 1995-05-19 | 1997-03-04 | Becton, Dickinson And Company | Pre-fillable syringe and stopper assembly therefor |
TW574036B (en) * | 1998-09-11 | 2004-02-01 | Elan Pharm Inc | Stable liquid compositions of botulinum toxin |
US20120238504A1 (en) * | 1998-09-11 | 2012-09-20 | Solstice Neurosciences, Llc | Stable Formulations of Botulinum Toxin in Hydrogels |
DE60125986T3 (de) | 2000-02-08 | 2011-07-28 | Allergan, Inc., 92612, Calif. | Pharmazeutische Zusammensetzungen mit Botulinum Toxin |
US20060269575A1 (en) | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
DE10333317A1 (de) * | 2003-07-22 | 2005-02-17 | Biotecon Therapeutics Gmbh | Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA) |
GB2416122A (en) | 2004-07-12 | 2006-01-18 | Ipsen Ltd | Botulinum neurotoxin composition |
US20080045889A1 (en) * | 2004-07-21 | 2008-02-21 | Gerondale Scott J | Botoxo Needle Injector |
CN102499981B (zh) * | 2005-03-03 | 2016-08-03 | 雷文斯治疗公司 | 用于局部施用和经皮肤递送肉毒杆菌毒素的组合物和方法 |
CN101779949B (zh) * | 2005-03-09 | 2013-03-13 | 库蒂森斯股份公司 | 嵌入有微电子系统的三维粘合剂器件 |
JP2006314554A (ja) * | 2005-05-12 | 2006-11-24 | Mitsubishi Pharma Corp | ヘパリン溶液プレフィルドシリンジ包装体 |
CN101500603A (zh) | 2006-06-15 | 2009-08-05 | 诺华有限公司 | 节省佐剂的多剂量流感疫苗接种方案 |
GB0700523D0 (en) * | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
EP2117584B1 (en) * | 2007-02-15 | 2013-10-09 | Allergan, Inc. | Use of botulinum toxin and enzymes for treating bladder disorders |
EP1997509A1 (en) * | 2007-06-01 | 2008-12-03 | Merz Pharma GmbH & Co.KGaA | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
EP2048156A1 (en) * | 2007-10-12 | 2009-04-15 | Merz Pharma GmbH & Co.KGaA | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
MX2009012570A (es) * | 2007-06-01 | 2010-03-15 | Merz Pharma Gmbh & Co Kgaa | Proceso para proveer un relajante muscular estable a la temperatura a base del componente neurotoxico de la toxina botulinica en forma solida. |
WO2009003010A2 (en) | 2007-06-25 | 2008-12-31 | Becton, Dickinson And Company | Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution |
EP2170400B1 (en) | 2007-07-10 | 2012-07-25 | Medy-Tox, INC. | Pharmaceutical liquid composition of botulinum toxin with improved stability |
US9107815B2 (en) * | 2008-02-22 | 2015-08-18 | Allergan, Inc. | Sustained release poloxamer containing pharmaceutical compositions |
US8871807B2 (en) * | 2008-03-28 | 2014-10-28 | Ecolab Usa Inc. | Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids |
US8809392B2 (en) * | 2008-03-28 | 2014-08-19 | Ecolab Usa Inc. | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
US8801659B2 (en) * | 2008-05-30 | 2014-08-12 | Allergan, Inc. | Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form |
EP2367503A1 (en) * | 2008-11-25 | 2011-09-28 | AttenueX Technologies, Inc. | Implant with high vapor pressure medium |
WO2010096134A1 (en) | 2008-12-04 | 2010-08-26 | Botulinum Toxin Research Associates, Inc. | Extended length botulinum toxin formulation for human or mammalian use |
US8535062B2 (en) * | 2008-12-23 | 2013-09-17 | Simskin, Llc | Cutaneous surgical training model of the head, neck and shoulders |
CN102869373B (zh) * | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
US10471212B2 (en) * | 2009-10-29 | 2019-11-12 | W. L. Gore & Associates, Inc. | Silicone free drug delivery devices |
US20130211344A1 (en) * | 2009-12-31 | 2013-08-15 | Nestor Rodriguez | Medical components having coated surfaces exhibiting low friction and/or low gas/liquid permeability |
US20130078295A1 (en) * | 2010-06-09 | 2013-03-28 | Lipotec S.A. | Skin antiaging treatment |
EP2399601A1 (en) | 2010-06-24 | 2011-12-28 | Merz Pharma GmbH & Co. KGaA | Botulinum toxin therapy |
EP2619313B1 (en) * | 2010-09-26 | 2021-11-10 | Da Yu Enterprises, L.L.C. | Method of recombinant macromolecular production |
FR2966044B1 (fr) * | 2010-10-18 | 2012-11-02 | Sanofi Pasteur | Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium |
CN103930595A (zh) * | 2011-11-11 | 2014-07-16 | Sio2医药产品公司 | 用于药物包装的钝化、pH保护性或润滑性涂层、涂布方法以及设备 |
US10780228B2 (en) * | 2012-05-07 | 2020-09-22 | Medline Industries, Inc. | Prefilled container systems |
US20150297800A1 (en) * | 2012-07-03 | 2015-10-22 | Sio2 Medical Products, Inc. | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS |
CN106170582A (zh) | 2012-07-03 | 2016-11-30 | Sio2医药产品公司 | 药物包装的SiOx 阻隔物和涂布方法 |
US9133412B2 (en) | 2012-07-09 | 2015-09-15 | Tribofilm Research, Inc. | Activated gaseous species for improved lubrication |
US10980865B2 (en) * | 2012-08-10 | 2021-04-20 | Aquavit Pharmaceuticals, Inc. | Direct application system and method for the delivery of bioactive compositions and formulations |
WO2014026161A1 (en) * | 2012-08-10 | 2014-02-13 | Aquavit Pharmaceuticals, Inc. | Vitamin supplement compositions for injection |
WO2014052792A1 (en) | 2012-09-28 | 2014-04-03 | Sio2 Medical Products, Inc. | Halogenated or parylene polymer coating |
US9662450B2 (en) * | 2013-03-01 | 2017-05-30 | Sio2 Medical Products, Inc. | Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus |
US9937099B2 (en) * | 2013-03-11 | 2018-04-10 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging with low oxygen transmission rate |
CN110074968B (zh) * | 2013-03-11 | 2021-12-21 | Sio2医药产品公司 | 涂布包装材料 |
US9863042B2 (en) * | 2013-03-15 | 2018-01-09 | Sio2 Medical Products, Inc. | PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases |
DE102014101305A1 (de) * | 2014-02-03 | 2015-08-06 | Heraeus Medical Gmbh | Vorrichtung zum Lagern und Mischen von Knochenzement |
CN106535858A (zh) * | 2014-03-26 | 2017-03-22 | 纳诺麦德皮肤护理公司 | 用于液体或固体成分的经皮和透皮递送的柱塞状物质传送装置 |
EP3188706B1 (en) * | 2014-09-02 | 2019-10-09 | American Silver, LLC | Botulinum toxin and colloidal silver particles |
US20170238580A1 (en) * | 2014-11-11 | 2017-08-24 | Pressed Juicery, LLC | System and process for destroying c. botulinum spores in pressed beverage using thermal pascalization |
SG11201705019PA (en) * | 2014-12-23 | 2017-07-28 | Merz Pharma Gmbh & Co Kgaa | Botulinum toxin prefilled container |
SG11201706247VA (en) * | 2015-02-03 | 2017-08-30 | Merz Pharma Gmbh & Co Kgaa | Botulinum toxin prefilled container |
US20160346480A1 (en) * | 2015-05-15 | 2016-12-01 | Jonathan L. Gleason | Syringes and methods of using them to treat overactive bladder |
US9827282B2 (en) * | 2015-07-24 | 2017-11-28 | Bao Tran | Medication dispensing system |
TWI737742B (zh) * | 2016-06-22 | 2021-09-01 | 德商梅茲製藥有限兩合公司 | 肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用 |
-
2015
- 2015-12-22 SG SG11201706247VA patent/SG11201706247VA/en unknown
- 2015-12-22 WO PCT/EP2015/002600 patent/WO2016124213A1/en active Application Filing
- 2015-12-22 EP EP15820043.6A patent/EP3253364A1/en active Pending
- 2015-12-22 MX MX2017009380A patent/MX2017009380A/es unknown
- 2015-12-22 BR BR112017016759-0A patent/BR112017016759B1/pt active IP Right Grant
- 2015-12-22 CN CN201580073728.XA patent/CN107206175B/zh active Active
- 2015-12-22 JP JP2017540690A patent/JP6813492B2/ja active Active
- 2015-12-22 TW TW104143034A patent/TWI728964B/zh active
- 2015-12-22 AR ARP150104254A patent/AR103244A1/es unknown
- 2015-12-22 US US15/547,941 patent/US10406290B2/en active Active
- 2015-12-22 CA CA2974450A patent/CA2974450C/en active Active
- 2015-12-22 KR KR1020177024659A patent/KR102627068B1/ko active IP Right Grant
- 2015-12-22 AU AU2015381351A patent/AU2015381351B2/en active Active
- 2015-12-22 RU RU2017125279A patent/RU2722290C2/ru active
-
2017
- 2017-07-11 IL IL253429A patent/IL253429B/en unknown
-
2019
- 2019-07-01 US US16/459,382 patent/US11219717B2/en active Active
-
2020
- 2020-09-28 JP JP2020162291A patent/JP7053751B2/ja active Active
-
2021
- 2021-11-23 US US17/534,229 patent/US20220080127A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2974450C (en) | 2024-01-09 |
IL253429A0 (en) | 2017-09-28 |
KR102627068B1 (ko) | 2024-01-18 |
JP7053751B2 (ja) | 2022-04-12 |
MX2017009380A (es) | 2018-01-09 |
AU2015381351B2 (en) | 2020-05-14 |
EP3253364A1 (en) | 2017-12-13 |
TW201637641A (zh) | 2016-11-01 |
JP2018506351A (ja) | 2018-03-08 |
US20190336691A1 (en) | 2019-11-07 |
CN107206175A (zh) | 2017-09-26 |
CN107206175B (zh) | 2021-06-01 |
IL253429B (en) | 2021-08-31 |
WO2016124213A1 (en) | 2016-08-11 |
RU2017125279A (ru) | 2019-03-04 |
JP2021041173A (ja) | 2021-03-18 |
BR112017016759B1 (pt) | 2021-01-12 |
TWI728964B (zh) | 2021-06-01 |
RU2722290C2 (ru) | 2020-05-28 |
US11219717B2 (en) | 2022-01-11 |
BR112017016759A2 (pt) | 2018-04-10 |
KR20170109051A (ko) | 2017-09-27 |
CA2974450A1 (en) | 2016-08-11 |
US20180015225A1 (en) | 2018-01-18 |
AU2015381351A1 (en) | 2017-08-03 |
US10406290B2 (en) | 2019-09-10 |
JP6813492B2 (ja) | 2021-01-13 |
SG11201706247VA (en) | 2017-08-30 |
RU2017125279A3 (es) | 2019-08-12 |
US20220080127A1 (en) | 2022-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR103244A1 (es) | Recipiente precargado con toxina botulínica | |
MX2017007476A (es) | Recipiente precargado con toxina botulinica. | |
CL2016002269A1 (es) | Moduladores alostéricos del núcleo proteico de la hepatitis b. | |
MX2015004636A (es) | Motores químicos y métodos para su uso, especialmente en la inyección de fluidos altamente viscosos. | |
AU367093S (en) | Medical injector | |
AU201611489S (en) | Drug applicator with massage head | |
EA201692105A1 (ru) | Новые пиразолопиримидиновые производные и их применение в качестве ингибиторов malt1 | |
CL2015002472A1 (es) | Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4. | |
AU367108S (en) | Medical injector | |
CL2015002860A1 (es) | Antagonistas de la alfa-v-beta-6 integrina | |
AU367095S (en) | Medical injector | |
WO2014145906A3 (en) | A prefilled medication device, method of making and using the same | |
MX2018006171A (es) | Jeringa de plastico precargada que contiene un antagonista de vegf. | |
CL2015003019A1 (es) | Derivados biaromáticos antibacterianos | |
CL2014003148A1 (es) | Composición farmacéutica acuosa que contiene un agente terapéutico biológico y guanidina o un derivado de la guanidina y una inyección que incluye la composición. | |
CL2015002592A1 (es) | Método y sistema para grabar contenidos recomendados por medio del uso de agrupadores de contenidos | |
EP3230457A4 (en) | Clostridial neurotoxin fusion proteins, propeptide fusions, their expression, and use | |
HK1232165A1 (zh) | 注射器蓋、帶針注射器、及預充式注射器製劑 | |
CR20180080A (es) | Combinaciones de un anticuerpo ox40 y un modulador de tlr4 y usos de las mismas | |
EP3406281A4 (en) | SYNTHETIC RESIN EXTERNAL CYLINDER FOR SYRINGE, SYRINGE, PRE-FILLED SYRINGE, AND STERILIZED SYNTHETIC RESIN CONTAINER FILLED WITH LIQUID | |
CL2016002608A1 (es) | Nuevo activador de suelo que comprende lignosulfonato de amonio, y usos del mismo | |
CL2016000944A1 (es) | Nueva formulación de ganadotropinas | |
TWD170704S (zh) | 香水瓶 | |
EP3169385A4 (en) | Syringe and fluid injection system with an orientation independent identification code | |
BR112017014262A2 (pt) | películas de embalagem com opacidade aumentada |